A Comparison of Intravenous Infliximab Versus Subcutaneous Infliximab on Remission Rates, Safety, Costs, Patient Preferences in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Gastro hep advances（2024）
Key words
Crohn’s Disease,Ulcerative Colitis,CT-P13,Biologic Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined